Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity

被引:24
作者
Wei, Meng-Xue [1 ]
Yu, Jia-Ying [1 ]
Liu, Xin-Xin [1 ]
Li, Xue-Qiang [1 ]
Zhang, Meng-Wei [1 ]
Yang, Pei-Wen [1 ]
Yang, Jin-Hui [1 ]
机构
[1] Ningxia Univ, Coll Chem & Chem Engn, Ningxia Engn Res Ctr Nat Med,Natl Demonstrat Ctr, State Key Lab High Efficiency Utilizat Coal & Gre, 489 Helanshan West Rd, Yinchuan 750021, Ningxia, Peoples R China
基金
中国国家自然科学基金;
关键词
Furan ether; Artemisinin; X-ray crystallography; Cytotoxic activity; Cancer cells; ANTICANCER ACTIVITY; CANCER-CELLS; DERIVATIVES; INHIBITION; APOPTOSIS; TARGET; DRUG;
D O I
10.1016/j.ejmech.2021.113295
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For the first time, eight novel artemisinin-piperazine-furane ether hybrids (5a-h) were efficiently synthesized and investigated for their in vitro cytotoxic activity against some human cancer and benign cells. The absolute configuration of hybrid 5c was determined by X-ray crystallographic analysis. Hybrids 5a-h exhibited more pronounced growth-inhibiting action on hepatocarcinoma cell lines than their parent dihydroartemisinin (DHA) and the reference cytosine arabinoside (ARA). The hybrid 5a showed the best cytotoxic activity against human hepatocarcinoma cells SMMC-7721 (IC50 = 0.26 +/- 0.03 mM) after 24 h. Furthermore, hybrid 5a also showed good cytotoxic activity against human breast cancer cells MCF-7 and low cytotoxicity against human breast benign cells MCF-10A in vitro. We found the cytotoxicity of hybrid 5a did not change when tumour cells absorb iron sulfate (FeSO4); thus, we conclude the anti-tumour mechanism induced by iron ions (Fe2+) is unclear. (c) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:10
相关论文
共 35 条
[1]   Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives [J].
Bhaw-Luximon, Archana ;
Jhurry, Dhanjay .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) :451-466
[2]   Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549-Synthesis, structure-activity relationship and biological evaluation [J].
Byczek-Wyrostek, Anna ;
Kitel, Radoslaw ;
Rumak, Klaudia ;
Skonieczna, Magdalena ;
Kasprzycka, Anna ;
Walczak, Krzysztof .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 :687-697
[3]   ent-Labdane Diterpenoids from the Aerial Parts of Eupatorium obtusissmum [J].
Castillo, Quirico A. ;
Triana, Jorge ;
Eiroa, Jose L. ;
Calcul, Laurent ;
Rivera, Edwin ;
Wojtas, Lukasz ;
Padron, Jose M. ;
Boberieth, Lise ;
Keramane, Mehdi ;
Abel-Santos, Ernesto ;
Baez, Luis A. ;
Germosen, Evelyn A. .
JOURNAL OF NATURAL PRODUCTS, 2016, 79 (04) :907-913
[4]   Multifunctional mesoporous nanoparticles as pH-responsive Fe2+ reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth [J].
Chen, Jian ;
Guo, Zhen ;
Wang, Hai-Bao ;
Zhou, Jia-Jia ;
Zhang, Wei-Jie ;
Chen, Qian-Wang .
BIOMATERIALS, 2014, 35 (24) :6498-6507
[5]  
CHEN QH, 1993, ACTA CHIM SINICA, V51, P622
[6]  
CHEN QH, 1995, TETRAHEDRON-ASYMMETR, V6, P401
[7]   Holotransferrin Enhances Selective Anticancer Activity of Artemisinin against Human Hepatocellular Carcinoma Cells [J].
Deng, Xiao-rong ;
Liu, Zhao-xia ;
Liu, Feng ;
Pan, Lei ;
Yu, He-ping ;
Jiang, Jin-ping ;
Zhang, Jian-jun ;
Liu, Li ;
Yu, Jun .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (06) :862-865
[8]   Artemisinins target the SERCA of Plasmodium falciparum [J].
Eckstein-Ludwig, U ;
Webb, RJ ;
van Goethem, IDA ;
East, JM ;
Lee, AG ;
Kimura, M ;
O'Neill, PM ;
Bray, PG ;
Ward, SA ;
Krishna, S .
NATURE, 2003, 424 (6951) :957-961
[9]   Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron [J].
Efferth, T ;
Benakis, A ;
Romero, MR ;
Tomicic, M ;
Rauh, R ;
Steinbach, D ;
Häfer, R ;
Stamminger, T ;
Oesch, F ;
Kaina, B ;
Marschall, M .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (07) :998-1009
[10]  
Efferth T., 2015, World J Tradit Chin Med, V1, P2, DOI 10.15806/j.issn.2311-8571.2015.0036